115 related articles for article (PubMed ID: 8647655)
21. Effect of resveratrol on growth of 4T1 breast cancer cells in vitro and in vivo.
Bove K; Lincoln DW; Tsan MF
Biochem Biophys Res Commun; 2002 Mar; 291(4):1001-5. PubMed ID: 11866465
[TBL] [Abstract][Full Text] [Related]
22. Effect of medroxyprogesterone acetate on the growth of mouse transplanted tumors: relation with hormone sensitivity.
Formelli F; Ronchi E; Di Fronzo G
Anticancer Res; 1985; 5(3):313-9. PubMed ID: 3160299
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of growth inhibition of mammary carcinomas by glucarate and the glucarate: retinoid combination.
Webb TE; Abou-Issa H; Stromberg PC; Curley RC; Nguyen MH
Anticancer Res; 1993; 13(6A):2095-9. PubMed ID: 8297119
[TBL] [Abstract][Full Text] [Related]
24. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA
Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177
[TBL] [Abstract][Full Text] [Related]
25. Tumor-inhibiting potential of ZK 112.993, a new progesterone antagonist, in hormone-sensitive, experimental rodent and human mammary tumors.
Schneider MR; Michna H; Nishino Y; Neef G; el Etreby MF
Anticancer Res; 1990; 10(3):683-7. PubMed ID: 2369083
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-12 inhibits angiogenesis and growth of transplanted but not in situ mouse mammary tumor virus-induced mammary carcinomas.
Lee JC; Kim DC; Gee MS; Saunders HM; Sehgal CM; Feldman MD; Ross SR; Lee WM
Cancer Res; 2002 Feb; 62(3):747-55. PubMed ID: 11830529
[TBL] [Abstract][Full Text] [Related]
27. Dietary lariciresinol attenuates mammary tumor growth and reduces blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats.
Saarinen NM; Wärri A; Dings RP; Airio M; Smeds AI; Mäkelä S
Int J Cancer; 2008 Sep; 123(5):1196-204. PubMed ID: 18528864
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of rate of tumor growth by creatine and cyclocreatine.
Miller EE; Evans AE; Cohn M
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3304-8. PubMed ID: 8475072
[TBL] [Abstract][Full Text] [Related]
29. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
[TBL] [Abstract][Full Text] [Related]
30. Direct inhibiting effects of [D-Trp6]gonadotropin-releasing hormone on the estrogen-sensitive progression of polyoma virus-induced mammary tumors in athymic mice.
Néri C; Blangy D; Schatz B; Drieu K; Berebbi M; Martin PM
Cancer Res; 1990 Sep; 50(18):5892-7. PubMed ID: 2168284
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
[TBL] [Abstract][Full Text] [Related]
32. The effect of 2-methoxyoestrone-3-O-sulphamate on the growth of breast cancer cells and induced mammary tumours.
Purohit A; Hejaz HA; Walden L; MacCarthy-Morrogh L; Packham G; Potter BV; Reed MJ
Int J Cancer; 2000 Feb; 85(4):584-9. PubMed ID: 10699934
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the growth of various human and mouse tumor cells by 1,15-bis(ethylamino)-4,8,12-triazapentadecane.
Igarashi K; Koga K; He Y; Shimogori T; Ekimoto H; Kashiwagi K; Shirahata A
Cancer Res; 1995 Jun; 55(12):2615-9. PubMed ID: 7780977
[TBL] [Abstract][Full Text] [Related]
34. Tumor types derived from epithelial and myoepithelial cell lines of R3230AC rat mammary carcinoma.
Sapino A; Papotti M; Sanfilippo B; Gugliotta P; Bussolati G
Cancer Res; 1992 Mar; 52(6):1553-60. PubMed ID: 1540965
[TBL] [Abstract][Full Text] [Related]
35. Platinum complexes with a selective action on estrogen receptor-positive mammary tumors.
von Angerer E; Birnböck H; Knebel N
Anticancer Drug Des; 1989 Jun; 4(1):21-35. PubMed ID: 2757751
[TBL] [Abstract][Full Text] [Related]
36. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
Guo Y; Mazar AP; Lebrun JJ; Rabbani SA
Cancer Res; 2002 Aug; 62(16):4678-84. PubMed ID: 12183425
[TBL] [Abstract][Full Text] [Related]
37. The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors.
Janik P; Briand P; Hartmann NR
Cancer Res; 1975 Dec; 35(12):3698-704. PubMed ID: 1192428
[TBL] [Abstract][Full Text] [Related]
38. [Animal experimental models of breast cancer for therapeutic testing of hormones and antihormones].
Naundorf H
Arch Geschwulstforsch; 1988; 58(5):345-56. PubMed ID: 3060043
[TBL] [Abstract][Full Text] [Related]
39. Oxytocin synthesis and oxytocin receptor expression by cell lines of human small cell carcinoma of the lung stimulate tumor growth through autocrine/paracrine signaling.
Péqueux C; Breton C; Hendrick JC; Hagelstein MT; Martens H; Winkler R; Geenen V; Legros JJ
Cancer Res; 2002 Aug; 62(16):4623-9. PubMed ID: 12183418
[TBL] [Abstract][Full Text] [Related]
40. EGF receptors in R3230AC rat mammary carcinomas: characteristics and regulation in vitro and in vivo.
Ryan PD; Hilf R
Oncol Res; 1992; 4(4-5):181-92. PubMed ID: 1504378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
